XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 164 filers reported holding XENON PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,096,535 | -77.8% | 178,470 | -75.0% | 0.03% | -76.9% |
| Q2 2023 | $27,430,403 | -22.3% | 712,478 | -27.8% | 0.12% | -32.8% |
| Q1 2023 | $35,295,919 | -24.9% | 986,195 | -17.2% | 0.17% | -39.4% |
| Q4 2022 | $46,986,286 | -28.8% | 1,191,638 | -34.9% | 0.29% | -32.0% |
| Q3 2022 | $66,032,000 | +18.7% | 1,829,152 | 0.0% | 0.42% | +25.6% |
| Q2 2022 | $55,643,000 | +100.1% | 1,829,152 | +101.1% | 0.34% | +131.7% |
| Q1 2022 | $27,807,000 | – | 909,628 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 266,961 | $9,119,388 | 10.70% |
| COMMODORE CAPITAL LP | 1,845,000 | $63,025,200 | 7.37% |
| TLS Advisors LLC | 32,956 | $1,126 | 4.56% |
| Altium Capital Management LP | 228,000 | $7,788,480 | 4.06% |
| Paradigm Biocapital Advisors LP | 1,491,835 | $50,961,084 | 3.46% |
| GREAT POINT PARTNERS LLC | 500,001 | $17,080,034 | 3.11% |
| DAFNA Capital Management LLC | 280,538 | $9,583,178 | 2.98% |
| Nan Fung Group Holdings Ltd | 106,680 | $3,644,189 | 2.95% |
| Affinity Asset Advisors, LLC | 300,438 | $10,262,962 | 2.89% |
| Avoro Capital Advisors LLC | 4,900,000 | $167,384,000 | 2.61% |